TCL Archive ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent. March 21, 2008
TCL Archive Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers November 21, 2014
TCL Archive Centers, Control to Be In New Division; Upton Moves Fink Up; Terry Acting Director Of DCCR May 4, 1979
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
